Floatz logo

METHOTREXATE

Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent

Princess Maxima Center for Pediatric OncologySmall moleculePhase 3Active
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent cohort.

Asset / SponsorPhaseRating
Inno-206
Princess Maxima Center for Pediatric Oncology
Phase 3BB
Cytosin-Arabinosid
Princess Maxima Center for Pediatric Oncology
Phase 3BB
Cyclophosphamide
Children's Oncology Group
Phase 3BB
Venetoclax
Princess Maxima Center for Pediatric Oncology
Phase 2/3B
DEXAMETHASONE
Children's Oncology Group
Phase 3B

View all 11 →

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →